Scott J. Jacober

4.3k total citations · 1 hit paper
64 papers, 3.2k citations indexed

About

Scott J. Jacober is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Scott J. Jacober has authored 64 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Scott J. Jacober's work include Diabetes Management and Research (38 papers), Diabetes Treatment and Management (30 papers) and Pancreatic function and diabetes (16 papers). Scott J. Jacober is often cited by papers focused on Diabetes Management and Research (38 papers), Diabetes Treatment and Management (30 papers) and Pancreatic function and diabetes (16 papers). Scott J. Jacober collaborates with scholars based in United States, Singapore and Hungary. Scott J. Jacober's co-authors include Anthony J. Zagar, David M. Kendall, Ronald Goldberg, Meng H. Tan, John B. Buse, Mehmood Khan, Mark A. Deeg, James R. Sowers, Yongming Qu and Alfonso T. Perez and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Scott J. Jacober

64 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

2005 626 citations Anthony J. Zagar, Scott J. Jacober et al. Diabetes Care profile →

Peers

Countries citing papers authored by Scott J. Jacober

Since Specialization

Citations

This map shows the geographic impact of Scott J. Jacober's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott J. Jacober with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott J. Jacober more than expected).

Fields of papers citing papers by Scott J. Jacober

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott J. Jacober. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott J. Jacober. The network helps show where Scott J. Jacober may publish in the future.

Co-authorship network of co-authors of Scott J. Jacober

This figure shows the co-authorship network connecting the top 25 collaborators of Scott J. Jacober. A scholar is included among the top collaborators of Scott J. Jacober based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott J. Jacober. Scott J. Jacober is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	754-P: A First-in-Human Single Ascending Dose Study of GSBR-1290, a Novel Small Molecule GLP-1 Receptor Agonist, in Healthy Volunteers 2023 ·Diabetes ·Blai Coll, (unknown), Scott J. Jacober, (unknown), (unknown), (unknown), Mark A. Bach	1
2	Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes 2017 ·Diabetes Obesity and Metabolism ·(unknown), Esben Søndergaard, Helle Linnebjerg, Parag Garhyan, (unknown), Niels Pörksen, Scott J. Jacober, Søren Nielsen	7
3	A Clinical Utility Index for Selecting an Optimal Insulin Dosing Algorithm for LY2605541 in Patients with Type 2 Diabetes Pretreated with Basal Insulin 2014 ·Diabetes Technology & Therapeutics ·(unknown), Junxiang Luo, Yongming Qu, Scott Berry, Brenda Gaydos, Scott J. Jacober	1
4	Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism 2013 ·Diabetes ·Mary Courtney Moore, Marta S. Smith, Vikram Sinha, John M. Beals, M. Dodson Michael, Scott J. Jacober, Alan D. Cherrington	68
5	Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability Data 2012 ·Diabetes Technology & Therapeutics ·Yongming Qu, Scott J. Jacober, Qianyi Zhang, (unknown), J. Hans DeVries	98
6	Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes 2012 ·Diabetes Care ·Julio Rosenstock, Richard M. Bergenstal, Thomas Blevins, Linda Morrow, Melvin Prince, Yongming Qu, Vikram Sinha, Daniel C. Howey, Scott J. Jacober	81
7	Post Hoc Subgroup Analysis of the HEART2D Trial Demonstrates Lower Cardiovascular Risk in Older Patients Targeting Postprandial Versus Fasting/Premeal Glycemia 2011 ·Diabetes Care ·Itamar Raz, Antonio Ceriello, Peter W.F. Wilson, (unknown), Eric Wen Su, Lisa Kerr, (unknown), Zvonko Miličević, Scott J. Jacober	58
8	Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes 2010 ·European Journal of Endocrinology ·Scott M. Ocheltree, Marcus Hompesch, (unknown), Linda Morrow, (unknown), Scott J. Jacober	20
9	Addition of insulin lispro protamine suspension or insulin glargine to oral type 2 diabetes regimens: a randomized trial 2010 ·Diabetes Obesity and Metabolism ·Krzysztof Strojek, (unknown), Michelle A. Carey, Scott J. Jacober	18
10	A randomized, treat‐to‐target trial comparing insulin lispro protamine suspension and insulin detemir in insulin‐naive patients with Type 2 diabetes 2009 ·Diabetic Medicine ·Leon Fogelfeld, Mala Dharmalingam, (unknown), Colin Jones, (unknown), Scott J. Jacober	33
11	Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial 2009 ·Diabetes Care ·Itamar Raz, Peter W.F. Wilson, Krzysztof Strojek, Irina Kowalska, Velimir Božikov, Anselm K. Gitt, György Jermendy, Barbara N. Campaigne, Lisa Kerr, Zvonko Miličević, Scott J. Jacober	248
12	Primary care physician beliefs about insulin initiation in patients with type 2 diabetes 2008 ·International Journal of Clinical Practice ·Risa P. Hayes, James T. Fitzgerald, Scott J. Jacober	101
13	A comparison of intensive mixture therapy with basal insulin therapy in insulin‐naïve patients with type 2 diabetes receiving oral antidiabetes agents 2006 ·Diabetes Obesity and Metabolism ·Scott J. Jacober, Jamie Scism‐Bacon, Anthony J. Zagar	53
14	Condom Use, Pregnancy, and STDs in Adolescent Females With and Without Type 1 Diabetes 2003 ·The Diabetes Educator ·(unknown), Denise Charron-Prochownik, Susan M. Sereika, Julius Kitutu, Karen L. Peterson, Dorothy Becker, Scott J. Jacober, (unknown), Neil H. White	18
15	Prevalence and risk factors for vaginal Candidacolonization in women with type 1 and type 2 diabetes 2002 ·BMC Infectious Diseases ·(unknown), Scott J. Jacober, Jack D. Sobel, Betsy Foxman	185
16	An Update on Perioperative Management of Diabetes 1999 ·Archives of Internal Medicine ·Scott J. Jacober, James R. Sowers	76
17	The Reliability of the Diabetes Care Profile for African Americans 1998 ·Evaluation & the Health Professions ·James T. Fitzgerald, Robert M. Anderson, Larry D. Gruppen, Wayne K. Davis, (unknown), Scott J. Jacober, George Grunberger	59
18	Postpartum Abnormalities of Carbohydrate and Cellular Calcium Metabolism in Pregnancy Induced Hypertension 1993 ·American Journal of Hypertension ·James R. Sowers, Paul R. Standley, Scott J. Jacober, (unknown), (unknown)	34
19	Hyperinsulinemia, Insulin Resistance, and Hyperglycemia: Contributing Factors in the Pathogenesis of Hypertension and Atherosclerosis 1993 ·American Journal of Hypertension ·James R. Sowers, Paul R. Standley, Jeffrey L. Ram, Scott J. Jacober, (unknown), Kelly Rose	103
20	Quality of life activities associated with adherence to insulin infusion pump therapy in the treatment of insulin dependent diabetes mellitus 1989 ·Journal of Clinical Epidemiology ·Fredric M. Wolf, Scott J. Jacober, (unknown), Richard G. Cornell, John C. Floyd	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact